San Mateo, Calif. and Riyadh, Saudi Arabia — November 11, 2025 — RapidAI, the pioneer of Deep Clinical AI and global leader in intelligent imaging and workflow integration, today announced a strategic partnership and co-development with Saudi Health Holdings Company (HHC), the largest healthcare provider in the Middle East. Through this collaboration, RapidAI will serve as HHC’s enterprise provider of deep clinical AI across its 20 health clusters network of hospitals and clinics, supporting multiple disease states in neurology, cardiology, vascular, oncology, orthopedic, and beyond.
This partnership represents a key pillar of HHC’s innovation and digital transformation strategy, directly supported by the Health Sector Transformation Program – one of Saudi Arabia’s Vision 2030 programs. The program adopts new initiatives to advance healthcare quality and accessibility and raise the awareness of prevention before treatment through cutting-edge technologies that are secure, localized, and sustainable.
Built on the Rapid Enterprise™ Platform and driven by RapidAI’s deep clinical AI, underpinned by advanced foundation models trained on multimodal clinical data and advanced 3D visualization, this collaboration brings a new level of adaptability and intelligence to healthcare systems globally. Deep clinical AI at the core of RapidAI’s Enterprise Platform extends beyond traditional triage and notification to deliver characterization, quantification, visualization, and longitudinal tracking across disease states and service lines.
Ad Statistics
Times Displayed: 5243
Times Visited: 17 Brand-New FDA-cleared Advanced Ultrasound Medical Device available for sale or lease to Wound Care Centers or any other Medical Facilities.The Arobella 1000D is designed for non-contact or debridement ultrasound wound healing therapy, or any other wounds
By integrating imaging, reports, and structured clinical data, Rapid’s deep clinical AI is developed from real-world patient cases, enabling clinicians to make faster, more informed decisions while laying the groundwork for scalable, data-driven innovation across the entire healthcare system.
“This collaboration represents a major milestone for RapidAI,” said Karim Karti, CEO of RapidAI. “Our deep clinical AI platform delivers far more than alerts; it provides actionable clinical intelligence. Together with HHC, we’re building the infrastructure for country-wide AI-enabled care that reflects the vision and ambition of Vision 2030.”
“Partnering with RapidAI aligns perfectly with our goal to transform and innovate on how care is delivered across our hospitals, from stroke to cardiac, vascular, and oncology, and to localize these capabilities for the Kingdom’s Vision 2030,” said Nasser Al Huqbani, CEO of Health Holdings Company.
